Cargando…
Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review
PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292264/ https://www.ncbi.nlm.nih.gov/pubmed/33826041 http://dx.doi.org/10.1007/s10286-021-00801-w |
_version_ | 1783724794641907712 |
---|---|
author | Wang, Miao Wang, Wei Gao, Zhongbao Yin, Xi Chen, Tong Jiang, Ziying Wang, Zhenfu |
author_facet | Wang, Miao Wang, Wei Gao, Zhongbao Yin, Xi Chen, Tong Jiang, Ziying Wang, Zhenfu |
author_sort | Wang, Miao |
collection | PubMed |
description | PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinicians to recognize this syndrome and thereby reach a correct diagnosis and provide optimal treatments to improve prognosis in clinical practice. METHODS: Using the methodology described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, we conducted a literature search of the PubMed, Embase, and MEDLINE databases using keywords in titles and abstracts of published literature. Quality assessment was performed using the modified Newcastle-Ottawa scale. RESULTS: A total of 11 patients obtained from nine publications were included in this systematic review. All of the cases occurred in patients with advanced Parkinson's disease (PD) of long disease duration. High ambient temperature was the most common trigger of this syndrome. Hyperpyrexia and dyskinesias were present in all cases. The consciousness disturbances of this syndrome included confusion, hallucination, and lethargy or stupor. Autonomic dysfunction (except for hyperpyrexia) is uncommon in DHS, and only two patients presented with tachycardia. The treatment of this syndrome included supportive interventions (including rehydration, anti-pyretic and anti-infection treatments, and maintaining electrolyte balance), dopaminergic drug reduction and sedation. Two patients died due to DHS. CONCLUSIONS: We summarized the triggers, clinical features, and treatments of all reported dyskinesia-hyperpyrexia syndrome cases, proposed guiding diagnostic criteria, and established a flow chart to guide diagnoses to quickly identify these three syndromes in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10286-021-00801-w. |
format | Online Article Text |
id | pubmed-8292264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82922642021-07-23 Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review Wang, Miao Wang, Wei Gao, Zhongbao Yin, Xi Chen, Tong Jiang, Ziying Wang, Zhenfu Clin Auton Res Review Article PURPOSE: Dyskinesia-hyperpyrexia syndrome (DHS) is a rare but life-threatening disease. The clinical manifestations of this syndrome overlap substantially with Parkinson hyperpyrexia syndrome and serotonin syndrome and are often confused by clinicians. The purpose of this review was to enable clinicians to recognize this syndrome and thereby reach a correct diagnosis and provide optimal treatments to improve prognosis in clinical practice. METHODS: Using the methodology described in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, we conducted a literature search of the PubMed, Embase, and MEDLINE databases using keywords in titles and abstracts of published literature. Quality assessment was performed using the modified Newcastle-Ottawa scale. RESULTS: A total of 11 patients obtained from nine publications were included in this systematic review. All of the cases occurred in patients with advanced Parkinson's disease (PD) of long disease duration. High ambient temperature was the most common trigger of this syndrome. Hyperpyrexia and dyskinesias were present in all cases. The consciousness disturbances of this syndrome included confusion, hallucination, and lethargy or stupor. Autonomic dysfunction (except for hyperpyrexia) is uncommon in DHS, and only two patients presented with tachycardia. The treatment of this syndrome included supportive interventions (including rehydration, anti-pyretic and anti-infection treatments, and maintaining electrolyte balance), dopaminergic drug reduction and sedation. Two patients died due to DHS. CONCLUSIONS: We summarized the triggers, clinical features, and treatments of all reported dyskinesia-hyperpyrexia syndrome cases, proposed guiding diagnostic criteria, and established a flow chart to guide diagnoses to quickly identify these three syndromes in clinical practice. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10286-021-00801-w. Springer Berlin Heidelberg 2021-04-07 2021 /pmc/articles/PMC8292264/ /pubmed/33826041 http://dx.doi.org/10.1007/s10286-021-00801-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Article Wang, Miao Wang, Wei Gao, Zhongbao Yin, Xi Chen, Tong Jiang, Ziying Wang, Zhenfu Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title | Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title_full | Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title_fullStr | Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title_full_unstemmed | Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title_short | Dyskinesia-hyperpyrexia syndrome in Parkinson’s disease: a systematic review |
title_sort | dyskinesia-hyperpyrexia syndrome in parkinson’s disease: a systematic review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292264/ https://www.ncbi.nlm.nih.gov/pubmed/33826041 http://dx.doi.org/10.1007/s10286-021-00801-w |
work_keys_str_mv | AT wangmiao dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT wangwei dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT gaozhongbao dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT yinxi dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT chentong dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT jiangziying dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview AT wangzhenfu dyskinesiahyperpyrexiasyndromeinparkinsonsdiseaseasystematicreview |